New drug hope for people with severe migraines
The drug, Aimovig, made by Amgen and Novartis, is a monthly injection with a device similar to an insulin pen. Aimovig blocks a protein fragment, CGRP, that instigates and perpetuates migraines Novartis India posts Q4 net at 26 cr
Novartis India today said it has posted a net profit of 26.47 crore for the quarter ended March of 2017-18.The company had posted a net profit of Corporate Action Fixes Book Closure For The Purpose Of Payment Of Final Dividend Upon Being Declared At The 70Th AGM Of The Company Scheduled On July 27, 2018
Book Closure Intimation for the purpose of payment of final dividend upon being declared at the 70th AGM of the Company scheduled on July 27, 2018 Corporate Action-Board approves Dividend
Recommendation of final dividend of Rs 10/- per equity share of Rs 5/- each for the year ended March 31, 2018 Board Meeting-Appointment of Managing Director
Appointment of Mr. Milan Paleja as the Vice Chairman & Managing Director of the Company with effect from June 1, 2018. A brief profile of Mr. Milan Paleja along with the press release is enclosed for your information; Results - Financial Results For 31/03/2018
Audited Financial Results for the financial year ended March 31, 2018 Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1230 Name of the Signatory :- Trivikram GudaDesignation :- Company Secretary and Compliance Officer
Glaxo, Novartis join Bill Gates led push to fight malaria
The commitments by Glaxo and Novartis to fight malaria are part of a pledge from the Bill & Melinda Gates Foundation